Guild Investment Management »

Relmada Therapeutics shares owned by Guild Investment Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Guild Investment Management from 13F filings

Historical chart of Guild Investment Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Guild Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Guild Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $221k 74k 3.00
2024-03-31 $888k 191k 4.65
2023-12-31 $878k 212k 4.14
2023-09-30 $616k 205k 3.00
2023-06-30 $274k 112k 2.46
2023-03-31 $235k 104k 2.26

More positions owned by Guild Investment Management

Sprott Asset Management Physical Gold Tr (PHYS)
Global X Fds 1-3 Month T-bill (CLIP)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
NVIDIA Corporation (NVDA)
Dell Technologies CL C (DELL)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
Invesco Exchange Traded Fd T S&p500 Eql Enr (RSPG)
Vaneck Etf Trust India Growth Ldr (GLIN)
Vaneck Etf Trust Gold Miners Etf (GDX)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Qualcomm (QCOM)

View all positions for Guild Investment Management

Top funds holding Relmada Therapeutics

Ikarian Capital
Driehaus Capital Management
Boothbay Fund Management
Acadian Asset Management
BlackRock
Vanguard Group
AdvisorShares Investments
Geode Capital Management
Marshall Wace
Parsons Capital Management
Deutsche Bank Aktiengesellschaft
CI Private Wealth
Susquehanna International
Two Sigma Investments
Renaissance Technologies

View all funds holding Relmada Therapeutics